Japan, Aug. 6 -- MITSUBISHI TANABE PHARMA CORP has got intellectual property rights for 'TRIAZINE COMPOUND SALT, CRYSTAL FORM THEREOF, AND PRODUCTION METHOD THEREFOR.' Other related details are as follows:

Application Number: JP,2025-112753

Category (FI): A61P27/02,A61P1/16,A61P3/04,A61P43/00,111,A61P9/04,C07D253/07,A61P25/00,A61K31/53,A61P9/12,A61P13/12,C07D295/15,A61P9/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 3, 2025

Publication Date: Oct. 1, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....